Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020;75(4):1437-1446.
doi: 10.3233/JAD-191291.

Examining Cognitive Decline Across Black and White Participants in the Harvard Aging Brain Study

Affiliations

Examining Cognitive Decline Across Black and White Participants in the Harvard Aging Brain Study

Rebecca E Amariglio et al. J Alzheimers Dis. 2020.

Abstract

Background: Black Americans are approximately twice as likely to develop dementia as compared to White Americans and the magnitude of this disparity is often attributed to a variety of factors that include psychosocial and vascular risk factors. However, less is known about the potential contribution of Alzheimer's disease pathological differences.

Objective: To examine potential differences incross-sectional and longitudinal cognitive performance in black and white participants who were clinically normal at baseline.

Methods: 296 participants (48 African-American/black participants) underwent MRI and amyloid PET at baseline. Linear mixed models were used to examine the main effects of race, years of education, reading ability, Framingham Heart Study cardiovascular risk score (FHS-CVD), white matter hyperintensities (WMH), and amyloid (Aβ) burden on the Preclinical Alzheimer Cognitive Composite-5 (PACC5).

Results: Lower levels of educationalattainment and reading ability were found for blacks compared to whites. By contrast, no differences in FHS-CVD, WMH, or Aβ were found by racial group. Baseline differences in PACC5 score were attenuated after adjusting for educationalfactors, vascular factors, and Aβ, but remained lower for blacks compared to whites (β= -0.24, p = 0.014). Further, blacks demonstrated a faster rate of PACC5 decline longitudinally compared to whites (β = -0.055, p = 0.025) after adjusting for covariates.

Conclusion: Accounting for educationalfactors, vascular factors, and Aβ burden diminished, but did not eliminate, racial differences in PACC5 performance longitudinally. Understanding potential differences in longitudinal cognitive outcomes by race may be important for upcoming secondary prevention trials.

Keywords: African-American; amyloid; cognitive decline; preclinical Alzheimer’s disease.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Longitudinal cognitive trajectories of participants by race PACC=Preclinical Alzheimer’s cognitive composite (z score), time is in years. Model controlling for demographic factors, educational factors, vascular factors, and amyloid. Continuous variables centered to sample mean.
Figure 2.
Figure 2.
Longitudinal PACC performance as a function of race and amyloid level (by tertile). ACC=Preclinical Alzheimer’s cognitive composite (z score), time is in years. Model controlling for demographic factors and educational factors. Continuous variables centered to sample mean.

References

    1. Mehta KM, Yeo G (2017) Systematic review of dementia prevalence and incidence in United States race/ethnic populations. Alzheimers Dement 13, 72–83. - PubMed
    1. Tang MX, Cross P, Andrews H, Jacobs DM, Small S, Bell K, Merchant C, Lantigua R, Costa R, Stern Y, Mayeux R (2001) Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology 56, 49–56. - PubMed
    1. Weuve J, Barnes LL, Mendes de Leon CF, Rajan KB, Beck T, Aggarwal NT, Bennett DA, Wilsosn RS, Evans DA (2018) Cognitive Aging in Black and White Americans: Cognition, Cognitive Decline, and Incidence of Alzheimer Disease Dementia. Epidemiology 29, 151–159. - PMC - PubMed
    1. Barnes LL, Bennett DA (2014) Alzheimer’s disease in African Americans: risk factors and challenges for the future. Health Aff (Millwood) 33, 580–586. - PMC - PubMed
    1. Barnes LL, Wilson RS, Li Y, Aggarwal NT, Gilley DW, McCann JJ, Evans DA(2005) Racial differences in the progression of cognitive decline in Alzheimer disease. Am J Geriatr Psychiatry 13, 959–967. - PubMed

Publication types

MeSH terms